Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation. - Wikidata - awgldk - TriplyDB

Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation.

Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation.

http://www.wikidata.org/entity/Q33944763

about

Improving medication adherence among kidney transplant recipients: Findings from other industries, patient engagement, and behavioral economics-A scoping review An overview of disparities and interventions in pediatric kidney transplantation worldwide Nonadherence Behaviors and Some Related Factors in Kidney Transplant Recipients.Should we retransplant a patient who is non-adherent? A literature review and critical reflection.Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study Standardized Outcomes in Nephrology-Transplantation: A Global Initiative to Develop a Core Outcome Set for Trials in Kidney Transplantation.Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine.Emerging drugs for the treatment of transplant rejection.Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomes.Pretransplant identification of acute rejection risk following kidney transplantation.Extended-release tacrolimus: a review of its use in de novo kidney transplantation.Generic immunosuppression in transplantation: current evidence and controversial issues.Identifying endpoints to predict the influence of immunosuppression on long-term kidney graft survival.Understanding Medication Nonadherence after Kidney Transplant.Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?Adherence in pediatric kidney transplant recipients: solutions for the system.Pill burden does not influence compliance with oral medication in recipients of renal transplant.Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation.Factors relevant to medication non-adherence in kidney transplant: a systematic review.Efficacy of interventions for adherence to the immunosuppressive therapy in kidney transplant recipients: a meta-analysis and systematic review.Factors that determine self-reported immunosuppressant adherence in kidney transplant recipients: a correlational study.Prediction of medication non-adherence and associated outcomes in pediatric kidney transplant recipients.Medication adherence and rejection rates in older vs younger adult liver transplant recipients.Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients.High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant Patients.Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation.Efficacy of a reduced pill burden on therapeutic adherence to calcineurin inhibitors in renal transplant recipients: an observational study.Renal association clinical practice guideline in post-operative care in the kidney transplant recipient A single daily dose enhances the adherence to immunosuppressive treatment in kidney transplant recipients: a cross-sectional study.Feelings of indebtedness and guilt toward donor and immunosuppressive medication adherence among heart transplant (HTx) patients, as assessed in a cross-sectional study with the Basel Assessment of Adherence to Immunosuppressive Medications Scale (B Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study.Psychosocial predictors of adherence after liver transplant in a single transplant center in Portugal.Prevalence and correlates of non-adherence to immunosuppressants and to health behaviours in patients after kidney transplantation in Brazil - the ADHERE BRAZIL multicentre study: a cross-sectional study protocol.Association of the combination of time-weighted variability of tacrolimus blood level and exposure to low drug levels with graft survival after kidney transplantation.Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient.Digital Medicine: Innovative Drug-Device Combination as New Measure of Medication Adherence.

P2860

Q26770369-29C114B7-7117-420A-9711-C5080E42E8A8 Q26851550-AB1B0E37-0B37-4AF2-BF20-0A0154CD4A85 Q33723131-88CF2DEE-4EE2-40C2-AC78-BD5D37965DD8 Q34247397-FEC17D5E-0069-40AB-952A-4C4E329AFA4B Q34448814-CEE4A4EF-26D6-489B-A85A-21B83F0ED765 Q37097834-9107859C-13F2-4DF5-898E-6C85D797510B Q37641415-07B2AD04-AFC3-4D96-A0DD-B254BD3C39BE Q37960177-20985431-B5EB-4C81-B043-C0AFC2EFC2C0 Q38061086-BC563786-8EE1-4B6C-85DC-72903027916E Q38151922-050917EF-8109-4C74-B6A4-80FF05340239 Q38263466-87DFF8E0-3CC9-4A15-9BAB-EF79EAD7194A Q38393905-7BEE593F-C9D8-4E45-9676-B72CD1951DAD Q38429887-939ADDAE-A488-49F7-8706-468A651C6A52 Q38718380-38A10569-6467-4837-8309-BCA06151CD22 Q38736961-FC8AF42A-5D7F-43A9-8036-3DD832D51B01 Q38738778-311526DE-4D8D-4876-B823-71A02EE56F35 Q38776675-8253E368-E6B4-4740-93EC-D6B41C5A648B Q38786418-70E4651D-99D4-42AA-ACD1-88E538F3B244 Q38856940-4572DC5A-4DBF-4C85-96D5-F2EE3DEFB051 Q39292308-1447F94F-B7A8-4CAF-A1C9-5F741D81EF10 Q39482872-0BE3834A-304D-4AC7-AC12-1B4B508017F3 Q40275918-67DB790D-F0F6-4356-8A9E-A25D5DACFB9B Q40458302-816850D7-C947-4A6A-919A-58E073F1FF90 Q40537018-59CFB11D-23AB-40DB-ABAA-9507BF4BCACC Q41217282-40FDEEFE-DEC0-4194-A5B8-22F27858280E Q41355218-0BA3D54A-5CB0-4265-9557-3D13EA21A513 Q41871356-CCBA310B-D717-4A90-8E01-3CF30F4A5708 Q42343473-3E013F77-FBC9-4058-BCDB-40E4CF21B49F Q46952602-90BD60FD-10C0-4748-AF84-0B435D7DF264 Q48145245-271F10BC-2518-454E-B9B8-C618D6C35CC0 Q48603070-3FEB80FF-44F5-4E3A-BF17-B673C26F9CCA Q48701466-E1DD7A78-7AEF-43BB-8687-B502D61C6EA1 Q49796222-13423DC6-13B6-4190-8BB1-BF2FB3233B4F Q50212034-2E04DC82-682B-4FD4-8080-515A63524CB2 Q52845695-B5CC0C61-1F27-4CE0-997D-11CD02AFF6F5 Q55262138-77181F5B-165C-48D4-A2B5-D48F803703F4

P2860

Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation.

http://www.wikidata.org/entity/Q33944763

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Optimizing medication adherenc ...... after kidney transplantation.

@ast

Optimizing medication adherenc ...... after kidney transplantation.

@en

type

label

Optimizing medication adherenc ...... after kidney transplantation.

@ast

Optimizing medication adherenc ...... after kidney transplantation.

@en

prefLabel

Optimizing medication adherenc ...... after kidney transplantation.

@ast

Optimizing medication adherenc ...... after kidney transplantation.

@en

P1433

Q33944763-172EAE56-CC6F-46BE-B0DC-22F8E1DE0D16

P1476

Q33944763-E81EA86E-F5FC-4DD6-BF86-99533D90F468

P2093

Q33944763-254B2F91-95AC-4AA2-9555-5BC8884EFCD4

Q33944763-7F593FD1-C824-44C9-A626-B2FBE97660F5

P2860

Q33944763-024A6129-7BB3-4CBA-A2ED-4056AE2BF101

Q33944763-098D71BB-A1EC-45A6-8B54-717B1554BC8E

Q33944763-0B562FFB-B9F5-4AB6-B344-107424545908

Q33944763-0BE4A4EC-9299-400E-A46D-45EF010FFB7A

Q33944763-0C2CA19D-08B6-424D-9017-9AC880C89F3B

Q33944763-0D73251F-90CF-4902-9587-67FB8ABAB2E3

Q33944763-1089D871-8E69-4AFF-8DB5-8EDE82DE63AE

Q33944763-12E29068-65D8-4F95-954C-E82BCE1EFE7E

Q33944763-168058D3-AE17-44DA-836C-6506CABBC1B1

Q33944763-1B57023A-66EA-42F1-8D20-D39440D41E34

P304

Q33944763-078883F1-2A57-441E-A86E-CDD73C1D0FC6

P31

Q33944763-3F9837FA-A411-4E06-82AF-C7880196EFC3

P356

Q33944763-80D36211-777A-4483-BCCA-DF320838B95B

P433

Q33944763-5C94DDD5-084E-4C31-90A6-F6C553189713

P478

Q33944763-D745A6FA-02DA-4966-BF71-6AF3A0014BEA

P577

Q33944763-5C36D63C-67BD-4289-9326-3020C5C078BE

P698

Q33944763-632C88C3-21F1-4907-A9B6-5CE73E2F1CCE

P932

Q33944763-B6A8A645-5EF1-4E2A-9D70-C0C8704E46DB

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Optimizing medication adherenc ...... after kidney transplantation.

@en

P2093

Mary B Prendergast

http://www.w3.org/2001/XMLSchema#string

Robert S Gaston

http://www.w3.org/2001/XMLSchema#string

P2860

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

A systematic review of the associations between dose regimens and medication compliance.

Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients.

Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs.

Renal transplantation in black Americans.

Practical approach to determining costs and frequency of adverse drug events in a health care network.

Hospital admissions resulting from preventable adverse drug reactions.

The impact of reducing dose frequency on health outcomes.

Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes.

The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response.

P304

1305-1311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.07241009

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20448067

http://www.w3.org/2001/XMLSchema#string

P932

2893061

http://www.w3.org/2001/XMLSchema#string